Procalcitonin, c-reactive protein and neopterin levels in patients with coronary atherosclerosis. 2005

Fulya Ilhan, and Handan Akbulut, and Ilgm Karaca, and Ahmet Godekmerdan, and Erdogan Ilkay, and Vedat Bulut
Department of Immunology, Firat University, Medical Faculty Elazig, Turkey. fulhan23@yahoo.com

OBJECTIVE Recent studies demonstrate that the serum inflammatory markers increase in patients with atherosclerosis. We aimed to assess whether a difference exists between patients with acute coronary syndrome and patients with stable angina pectoris in respect to serum neopterin, procalcitonin (PCT) and C-reactive protein (CRP) levels. RESULTS A total of 52 patients (42 male, 10 female) who had atherosclerosis confirmed by angiography and were being followed up for an acute coronary syndrome were recruited and for control group, 45 patients with stable angina pectoris (SA) (35 male and 10 female) who underwent coronary angiography, were examined. Serum concentrations of neopterin, CRP and PCT in the study group (acute coronary syndrome) were compared to control group (stable angina pectoris). The mean neopterin level of the study group was 22.47 +/- 2.93 nmol/l, the mean CRP level was 30.40 +/- 8.05 mg/l and the mean PCT level was 0.40 +/- 0.04 ng/ml. In control group these levels were 12.26 +/- 0.61 nmol/l (p < 0.05), 5.26 +/- 0.64 mg/l (p < 0.001) and 0.19 +/- 0.02 ng/ml (p < 0.001), respectively. CONCLUSIONS In the presented study our results showed that these markers can be useful for the assessment of inflammation related to atherosclerosis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011498 Protein Precursors Precursors, Protein
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D005260 Female Females
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000787 Angina Pectoris The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION. Angor Pectoris,Stenocardia,Stenocardias

Related Publications

Fulya Ilhan, and Handan Akbulut, and Ilgm Karaca, and Ahmet Godekmerdan, and Erdogan Ilkay, and Vedat Bulut
January 2007, Bratislavske lekarske listy,
Fulya Ilhan, and Handan Akbulut, and Ilgm Karaca, and Ahmet Godekmerdan, and Erdogan Ilkay, and Vedat Bulut
April 2021, Cell journal,
Fulya Ilhan, and Handan Akbulut, and Ilgm Karaca, and Ahmet Godekmerdan, and Erdogan Ilkay, and Vedat Bulut
January 2009, Bratislavske lekarske listy,
Fulya Ilhan, and Handan Akbulut, and Ilgm Karaca, and Ahmet Godekmerdan, and Erdogan Ilkay, and Vedat Bulut
April 2021, International journal of clinical practice,
Fulya Ilhan, and Handan Akbulut, and Ilgm Karaca, and Ahmet Godekmerdan, and Erdogan Ilkay, and Vedat Bulut
February 1997, Acta paediatrica (Oslo, Norway : 1992),
Fulya Ilhan, and Handan Akbulut, and Ilgm Karaca, and Ahmet Godekmerdan, and Erdogan Ilkay, and Vedat Bulut
January 2006, Clinical chemistry and laboratory medicine,
Fulya Ilhan, and Handan Akbulut, and Ilgm Karaca, and Ahmet Godekmerdan, and Erdogan Ilkay, and Vedat Bulut
February 2011, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Fulya Ilhan, and Handan Akbulut, and Ilgm Karaca, and Ahmet Godekmerdan, and Erdogan Ilkay, and Vedat Bulut
January 2011, International journal of chronic obstructive pulmonary disease,
Fulya Ilhan, and Handan Akbulut, and Ilgm Karaca, and Ahmet Godekmerdan, and Erdogan Ilkay, and Vedat Bulut
October 2018, Internal medicine journal,
Fulya Ilhan, and Handan Akbulut, and Ilgm Karaca, and Ahmet Godekmerdan, and Erdogan Ilkay, and Vedat Bulut
January 2007, Cellular & molecular biology letters,
Copied contents to your clipboard!